https://www.selleckchem.com/pr....oducts/reparixin-rep
The result of xenograft tumor model showed that SZU-106-DAC-AML tumor vaccine greatly inhibited tumor growth and prolonged animal survival. Conclusions Conjugation of TLR7 agonist combined with up-regulation of tumor antigen expression improved the effectiveness of whole-cell tumor vaccine in AML.Background Diabetes mellitus is the leading cause of diabetic nephropathy and a major public health issue worldwide. Approximately -30% of patients with type 2 diabetes mellitus (T2DM) have renal impairment. Fatty acid-binding prot
Like
Comment
Share
